Hasegawa, Yutaka <br/><br/>
Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cells.  [electronic resource] 

 -  Molecular oncology  Jun 2008 
 - 54-69 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-0261 
<br/><br/><label>Standard No.: </label>10.1016/j.molonc.2008.03.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Adhesion Molecules--metabolism<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Humans<br/>Lysophospholipids--pharmacology<br/>Male<br/>Microfilament Proteins--metabolism<br/>Phosphoproteins--metabolism<br/>Prostatic Neoplasms--pathology<br/>Pseudopodia--drug effects<br/>Receptors, Lysophosphatidic Acid--physiology<br/>Vasodilator-Stimulated Phosphoprotein